Ozempic maker Novo Nordisk sues US rival over ‘materially misleading’ ads

Danish pharma company says Eli Lilly using outdated trial data to make its weight-loss drugs appear more effective Ozempic maker Novo Nordisk said on Tuesday it is suing arch US rival Eli Lilly over “false and materially misleading” adverts for its competing weight-loss and…

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on The Guardian.